Riegel v. Medtronic: A Win For Medical Technology
The court held that manufacturers of medical devices approved under the Food and Drug Administration’s pre-market approval (PMA) process cannot be sued under state law theories of product liability.
At the heart of this ruling was a federal statutory provision prohibiting states from imposing requirements "different from, or in addition to" existing federal requirements applicable to medical devices.
The court’s decision...
To view the full article, register now.